Preparation of Nanoparticle-Loaded Extracellular Vesicles Using Direct Flow Filtration

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 May 27

PMID 37242792

Authors

Shomit Mansur

Shahriar Habib

Mikayla Hawkins

Spenser R Brown

Steven T Weinman

Yuping Bao

Affiliations

Soon will be listed here.

Abstract

Extracellular vesicles (EVs) have shown great potential as cell-free therapeutics and biomimetic nanocarriers for drug delivery. However, the potential of EVs is limited by scalable, reproducible production and in vivo tracking after delivery. Here, we report the preparation of quercetin-iron complex nanoparticle-loaded EVs derived from a breast cancer cell line, MDA-MB-231br, using direct flow filtration. The morphology and size of the nanoparticle-loaded EVs were characterized using transmission electron microscopy and dynamic light scattering. The SDS-PAGE gel electrophoresis of those EVs showed several protein bands in the range of 20-100 kDa. The analysis of EV protein markers by a semi-quantitative antibody array confirmed the presence of several typical EV markers, such as ALIX, TSG101, CD63, and CD81. Our EV yield quantification suggested a significant yield increase in direct flow filtration compared with ultracentrifugation. Subsequently, we compared the cellular uptake behaviors of nanoparticle-loaded EVs with free nanoparticles using MDA-MB-231br cell line. Iron staining studies indicated that free nanoparticles were taken up by cells via endocytosis and localized at a certain area within the cells while uniform iron staining across cells was observed for cells treated with nanoparticle-loaded EVs. Our studies demonstrate the feasibility of using direct flow filtration for the production of nanoparticle-loaded EVs from cancer cells. The cellular uptake studies suggested the possibility of deeper penetration of the nanocarriers because the cancer cells readily took up the quercetin-iron complex nanoparticles, and then released nanoparticle-loaded EVs, which can be further delivered to regional cells.

Citing Articles

Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment.

Zheng L, Chang R, Liang B, Wang Y, Zhu Y, Jia Z Cancer Drug Resist. 2025; 7():50.

PMID: 39802949 PMC: 11724354. DOI: 10.20517/cdr.2024.107.

Cargo exchange between human and bacterial extracellular vesicles in gestational tissues: a new paradigm in communication and immune development.

Amabebe E, Kumar A, Tatiparthy M, Kumar Kammala A, Taylor B, Menon R Extracell Vesicles Circ Nucl Acids. 2024; 5(2):297-328.

PMID: 39698538 PMC: 11648491. DOI: 10.20517/evcna.2024.21.

Extracellular Vesicle-Mediated Modulation of Stem-like Phenotype in Breast Cancer Cells under Fluid Shear Stress.

Brown S, Radcliffe M, Danner J, Andujar Cruz W, Lackey K, Park H Biomolecules. 2024; 14(7).

PMID: 39062471 PMC: 11274421. DOI: 10.3390/biom14070757.

References

Singh A, Patnam S, Koyyada R, Samal R, Alvi S, Satyanaryana G . Identifying stable reference genes in polyethene glycol precipitated urinary extracellular vesicles for RT-qPCR-based gene expression studies in renal graft dysfunction patients. Transpl Immunol. 2022; 75:101715. DOI: 10.1016/j.trim.2022.101715. View

Margolis L, Sadovsky Y . The biology of extracellular vesicles: The known unknowns. PLoS Biol. 2019; 17(7):e3000363. PMC: 6667152. DOI: 10.1371/journal.pbio.3000363. View

Amsar R, Wijaya C, Ana I, Hidajah A, Notobroto H, Wungu T . Extracellular vesicles: a promising cell-free therapy for cartilage repair. Future Sci OA. 2022; 8(2):FSO774. PMC: 8765097. DOI: 10.2144/fsoa-2021-0096. View

Gonzalez-King H, Tejedor S, Ciria M, Gil-Barrachina M, Soriano-Navarro M, Sanchez-Sanchez R . Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes malignancy in poorly invasive MCF-7 cells. Cancer Gene Ther. 2022; 29(7):1056-1069. DOI: 10.1038/s41417-021-00411-8. View

Kim K, Park J, Jung J, Lee R, Park J, Yuk J . Cyclic tangential flow filtration system for isolation of extracellular vesicles. APL Bioeng. 2021; 5(1):016103. PMC: 7932758. DOI: 10.1063/5.0037768. View

Jeppesen D, Hvam M, Primdahl-Bengtson B, Boysen A, Whitehead B, Dyrskjot L . Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles. 2014; 3:25011. PMC: 4224706. DOI: 10.3402/jev.v3.25011. View

Schindler C, Collinson A, Matthews C, Pointon A, Jenkinson L, Minter R . Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency. PLoS One. 2019; 14(3):e0214545. PMC: 6440694. DOI: 10.1371/journal.pone.0214545. View

Ha D, Yang N, Nadithe V . Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016; 6(4):287-96. PMC: 4951582. DOI: 10.1016/j.apsb.2016.02.001. View

Gonzalez-Gonzalez L, Gonzalez-Ramirez R, Flores A, Avelino-Cruz J, Felix R, Monjaraz E . Epidermal Growth Factor Potentiates Migration of MDA-MB 231 Breast Cancer Cells by Increasing NaV1.5 Channel Expression. Oncology. 2019; 97(6):373-382. DOI: 10.1159/000501802. View

10.

Kreger B, Johansen E, Cerione R, Antonyak M . The Enrichment of Survivin in Exosomes from Breast Cancer Cells Treated with Paclitaxel Promotes Cell Survival and Chemoresistance. Cancers (Basel). 2016; 8(12). PMC: 5187509. DOI: 10.3390/cancers8120111. View

11.

Massi A, Bortolini O, Ragno D, Bernardi T, Sacchetti G, Tacchini M . Research Progress in the Modification of Quercetin Leading to Anticancer Agents. Molecules. 2017; 22(8). PMC: 6152094. DOI: 10.3390/molecules22081270. View

12.

Betzer O, Barnoy E, Sadan T, Elbaz I, Braverman C, Liu Z . Advances in imaging strategies for in vivo tracking of exosomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019; 12(2):e1594. DOI: 10.1002/wnan.1594. View

13.

Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B . Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease. Theranostics. 2023; 13(4):1264-1285. PMC: 10008732. DOI: 10.7150/thno.81860. View

14.

Salmond N, Williams K . Isolation and characterization of extracellular vesicles for clinical applications in cancer - time for standardization?. Nanoscale Adv. 2022; 3(7):1830-1852. PMC: 9419267. DOI: 10.1039/d0na00676a. View

15.

Barjesteh T, Mansur S, Bao Y . Inorganic Nanoparticle-Loaded Exosomes for Biomedical Applications. Molecules. 2021; 26(4). PMC: 7924372. DOI: 10.3390/molecules26041135. View

16.

Moce-Llivina L, Jofre J, Muniesa M . Comparison of polyvinylidene fluoride and polyether sulfone membranes in filtering viral suspensions. J Virol Methods. 2003; 109(1):99-101. DOI: 10.1016/s0166-0934(03)00046-6. View

17.

Sherwood J, Lovas K, Rich M, Yin Q, Lackey K, Bolding M . Shape-dependent cellular behaviors and relaxivity of iron oxide-based T MRI contrast agents. Nanoscale. 2016; 8(40):17506-17515. DOI: 10.1039/c6nr06158c. View

18.

Horibe S, Tanahashi T, Kawauchi S, Murakami Y, Rikitake Y . Mechanism of recipient cell-dependent differences in exosome uptake. BMC Cancer. 2018; 18(1):47. PMC: 5756423. DOI: 10.1186/s12885-017-3958-1. View

19.

Perocheau D, Touramanidou L, Gurung S, Gissen P, Baruteau J . Clinical applications for exosomes: Are we there yet?. Br J Pharmacol. 2021; 178(12):2375-2392. PMC: 8432553. DOI: 10.1111/bph.15432. View

20.

Xu Y, Sherwood J, Lackey K, Qin Y, Bao Y . The responses of immune cells to iron oxide nanoparticles. J Appl Toxicol. 2016; 36(4):543-53. DOI: 10.1002/jat.3282. View